Plunkett Research Online: Regen BioPharma Inc

REGEN BIOPHARMA INC (RGBP:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Regen BioPharma Inc is a US-based Biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company’s principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules a.....



Regen BioPharma Inc
Ticker: RGBP
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 619 702-1404
Fax: 619 330-2328
Address: 4700 Spring Street
Suite 304
La Mesa, CA 91942 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccines, Skin Replacement Products and Biologicals Manufacturing
ContactsDescription
David KoosCEO/Chairman of the Board/Director/Secretary/Treasurer
Todd CavenCFO
See More
Regen BioPharma Inc is a US-based Biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company’s principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules a.....See More See More

Auditor: AMC Auditing
Legal Advisor:
$USD, In whole numbers,
except marked * or %
20172016201520142013
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: